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Abstract
Background: The prevention of mother-to-child transmission of human immunodeficiency virus (HIV) is lauded as
one of the more successful HIV prevention measures. However, despite some gains in the prevention of mother-to-
child transmission of HIV (PMTCT) in sub-Saharan Africa, mother-to-child transmission rates are still high. In Kenya,
mother-to-child transmission is considered one of the greatest health challenges and scaling up PMTCT services is
crucial to its elimination by 2015. However, guideline implementation faces barriers that challenge scale-up of
services. The objective of this paper is to identify barriers to PMTCT implementation in the context of a
randomized control trial on the use of structured mobile phone messages in PMTCT.
Methods: The preliminary analysis presented here is based on survey data collected during enrolment in PMTCT
services at one of two health facilities in Nairobi, Kenya, with overall number of antenatal care (ANC) visits
determined from 48 hour follow up data.
Results: Data was collected for 503 women. Despite significant differences in the type of facility and sample
characteristics between sites, all women presented to care at 20 weeks gestation or later and 88.8% attended less
than four ANC visits. PMTCT counselling at first visit had high coverage (86%), however less than a third of women
(31.34%) reported receiving contraception counselling. Although 60.8% of women had reportedly disclosed their
status to their partners, only 40% were aware of their partner’s status. Very few women had been tested for TB
(10%) or received single dose nevirapine during their first antenatal care appointment (20%).
Conclusion: Revised PMTCT guidelines aim to reduce the inequity between PMTCT services in high and low
resource settings in efforts to eliminate mother-to-child transmission. However, guideline implementation in low
resource settings continues to be confronted with challenges related to late presentation, less than four ANC visits,
low screening rates for opportunistic infections, and limited contraception counselling. These challenges are further
complicated by lack of disclosure to partners. Effective scale up and implementation of PMTCT services requires
that such ongoing program challenges be identified and appropriately addressed within the local context.
Résumé
Contexte: La prévention de la transmission du virus de l’immunodéficience humaine (VIH) de la mère à l’enfant est
reconnue comme l’une des méthodes de prévention du VIH les plus efficaces. Cependant, bien que l’on ait réalisé
certains gains au chapitre de la prévention de la transmission du VIH de la mère à l’enfant (PTME) en Afrique
subsaharienne, les taux de transmission de la mère à l’enfant demeurent élevés. Au Kenya, la transmission de la
mère à l’enfant est considérée comme l’un des plus grands problèmes de santé, et il est crucial de faire passer à
grande échelle les services de PTME si l’on veut arriver à éliminer la transmission d’ici 2015. Toutefois, la mise en
oeuvre de lignes directrices est entravée par des obstacles qui freinent le passage à grande échelle des services.
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L’objectif du présent article est de présenter les facteurs qui font obstacle à la mise en oeuvre de la PTME dans le
contexte d’un essai comparatif avec répartition aléatoire sur l’utilisation d’un système de messages uniformisés pour
la PTME.
Méthodes: L’analyse préliminaire présentée ici s’appuie sur des données d’enquête recueillies durant l’inscription
aux services de PTME à l’un de deux établissements de santé de Nairobi, au Kenya, où le nombre de visites en
soins prénataux. Les données de suivi recueillies dans les 48 heures ont permis de déterminer le nombre de visites
en soins prénataux.
Résultats: Les données recueillies portaient sur 503 femmes. Si les deux établissements étaient très différents et
que les caractéristiques de l’échantillon variaient beaucoup d’un établissement à l’autre, toutes les femmes se sont
présentées à 20 semaines de gestation ou plus tard, et 88,8 % d’entre elles se sont présentées à moins de quatre
visites en soins prénataux. Bien que 86 % des femmes aient reçu des services de counselling en PTME, moins du
tiers (31,4 %) ont indiqué avoir reçu des conseils sur la contraception. De plus, tandis que 60,8 % des femmes ont
dit avoir révélé leur statut sérologique à leur partenaire, seulement 40 % d’entre elles connaissaient celui de leur
partenaire. Très peu de femmes avaient subi un test de dépistage de la tuberculose (10 %) ou reçu une dose
unique de névirapine à l’occasion de leur premier rendez-vous en soins prénataux (20 %).
Conclusion: Les lignes directrices en matière de PTME visent à réduire l’écart en matière de services de PTME
entre les milieux favorisés et les milieux démunis afin d’éliminer la transmission de la mère à l’enfant. Cependant, la
mise en oeuvre de ces lignes directrices dans les milieux défavorisés continue d’être entravée par des obstacles
reliés aux premiers rendez-vous tardifs, au nombre limité de visites (moins de quatre), aux faibles taux de dépistage
des infections opportunistes et au manque de services de counselling en contraception. Le fait que certaines
femmes ignorent le statut sérologique de leur partenaire ne fait qu’aggraver ces problèmes. Le passage à grande
échelle et la mise en oeuvre des services de PTME exigent que ces problèmes récurrents soient ciblés et abordés
adéquatement en fonction du contexte local.
Background
The prevention of mother-to-child transmission of
human immunodeficiency virus (HIV) is lauded as one
of the more successful HIV prevention strategies, with
substantial reductions in the number of HIV positive
children born to HIV positive women reported. Glob-
ally, it is estimated that 390 000 new paediatric infec-
tions were recorded in 2010, 15% less than reported in
2001 [1]. These reductions, however, seem concentrated
in the developed world where there is greater coverage
of prevention of mother-to-child transmission of HIV
(PMTCT) services and antiretroviral therapy (ART) [2].
Despite some gains in PMTCT in sub-Saharan Africa
(SSA), rates of mother-to-child transmission are still
high and 90% of paediatric infections occur here, high-
lighting the growing inequalities in global health [1,3].
In Kenya, the mother-to-child transmission of HIV is
considered to be one of the greatest health challenges with
an estimated 37 000 to 40 000 infants infected annually
[3]. Scaling up PMTCT services in the country is crucial
for Kenya to eliminate mother-to-child transmission by
2015, as recently called for by the Joint United Nations
Programme on HIV/AIDS. The implementation of current
PMTCT guidelines, however, faces certain barriers that
would also challenge scale-up. A recent review of the
implementation of Kenya’s PMTCT guidelines found that
although certain aspects of PMTCT services, such as
counselling and ART, had achieved reasonable coverage,
other aspects such as disease staging had more limited
coverage [4]. Although the development of national guide-
lines is one strategy to increase the effectiveness of
PMTCT services offered by healthcare providers [3],
inconsistent implementation of guidelines in low income
countries could be a hindrance to PMTCT services.
PMTCT guidelines in Kenya: 2012
In 2012, Kenya published revised PMTCT guidelines
based on WHO guidelines published in 2010 [3]. Based on
the four-pronged approach promoted by the WHO, it
focuses on primary prevention of HIV infection in women,
prevention of unintended pregnancies, reducing transmis-
sion during pregnancy, labour and breastfeeding, and pro-
viding support to HIV-positive women and their families.
As such, the Kenyan guidelines encourage four or more
antenatal care (ANC) visits with an essential package of
services that includes (but is not limited to) counselling,
medical history and examination, nutritional assessment,
testing for opportunistic infections including tuberculosis
(TB), positive prevention counselling (including disclosure,
condom use, psychosocial support for families), and an
effective contraception plan. The revised guidelines have a
much greater focus on pharmaceutical prophylaxis than
previous guidelines and promote earlier initiation of ther-
apy for all pregnant women. Women who are eligible to
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receive ART (CD4 cell count of 350 or below with WHO
clinical stage of I or II, or WHO clinical stage III or IV,
regardless of CD4 cell count) should be started on highly
active antiretroviral therapy (HAART) regardless of gesta-
tional age. Women not eligible for HAART should be
started on combination antiretroviral (ARV) prophylaxis
at 14 weeks, or shortly thereafter and receive a combina-
tion of AZT, 3TC, and NVP at the onset of labour. The
Kenyan guidelines include Option A (single dose nevari-
pine in labour) although option B is encouraged in settings
with the capacity to monitor women receiving triple ther-
apy. This could also be continued through the woman’s
life without interruption, known as option B PLUS. Infants
should receive single-dose nevirapine (sdNVP) within
72 hours of delivery, followed by 3TC and AZT. Infants
should receive nevirapine six weeks following birth if the
mother was on HAART before pregnancy or is not breast-
feeding. If the mother is breastfeeding, the infant should
receive nevirapine from birth to one week following the
last exposure to breast milk. The guidelines also instruct
that, at the first ANC visit, all HIV infected pregnant
women should be given sdNVP for themselves (to be
taken at the onset of labour) and for the infants-“to be
administered soon after birth” [3].
Kenya’s revised guidelines adhere closely to the best
evidence for PMTCT as captured in the WHO guide-
lines and could contribute to the elimination of mother-
to-child transmission by 2015, if implemented across the
country. Barriers to implementation, however, could
lead to inconsistent implementation and reduce the
guidelines’ impact. This paper examines adherence to
aspects of Kenya’s PMTCT guidelines, including number
of antenatal care visits, counselling (including family
planning and disclosure), and TB testing, based on data
collected during a study of mobile health (mHealth) in
PMTCT service delivery.
Methods
Study design and sampling
These results were obtained in the context of a rando-
mized control trial (RCT) on the use of structured
mobile phone messages in PMTCT. The goals of the
study were to improve linkage to ANC, provide remin-
ders to take PMTCT medications, and improve post-
natal support and follow-up – even when mothers deli-
ver elsewhere. In addition to benefits directly related to
PMTCT, the study also aimed to demonstrate that
mobile phone technology can be used as an effective
tool for strengthening health information systems at a
facility level by collecting better information, and
thereby advance local health systems development.
Women were recruited from the PMTCT clinic at Pum-
wani Maternity Hospital (PMH) and the ANC/PMTCT
clinic at Baba Dogo Health Centre (BDHC) in Nairobi,
Kenya and enrolled in the study during their first ANC
visit, if they met the inclusion criteria. They were consid-
ered eligible if they were HIV positive, pregnant with a sin-
gleton pregnancy, had never had a preterm birth, were
residing within 15 km of either study facility, and would
be residing there for at least six months post-delivery, lit-
erate in Kiswahili or English, were willing to be contacted
for follow up, and had regular access to a cell phone –
either their own or that of their partner or a family mem-
ber. Disclosure of HIV status to their partner was initially
included as criteria but was eliminated at the request of
key stakeholders who thought this would not be represen-
tative of women receiving PMTCT services in Kenya.
Women who were considered eligible were approached by
study nurses –not affiliated with either facility- who
explained the objectives and procedures of the study and
asked if they wanted to participate (one nurse was hired at
each facility). Nurses had experience working in maternal
health as well as previous experience working on research
projects. If women agreed to participate, informed consent
was obtained before conducting the baseline survey or col-
lecting samples.
Data collection and analysis
Survey data was collected at enrollment, during routine
ANC visits, and 48 hours and 6 weeks post-delivery. At
enrollment, women completed a brief questionnaire col-
lecting data on socio-demographic characteristics, cell
phone history, HIV status history, previous pregnancy,
current pregnancy, gender based violence, TB testing and
care, and PMTCT knowledge. Subsequent data collection
focused on ARV history, pregnancy complications, deliv-
ery and postpartum data, and perceptions of the mobile
phone intervention (intervention clients only).
The preliminary analysis presented here focuses on the
survey data collected at enrolment with the exception of
the number of ANC visits which was determined from
data collected at the 48 hour-follow up. We compared
variables of interest across the two hospital sites as we
were interested in determining whether or not there were
differences between sites, given the differences in popula-
tions served and clinical practice. Our assumption was
that while there may be differences by site, there may
also be broader structural barriers we could identify at
both sites. Data was analysed using Stata 11 (College Sta-
tion, TX) and descriptive analyses included comparisons
between women recruited from the different hospitals.
Chi-square tests of association were used to compare
variables of interest across the two hospital sites.
Ethical considerations
Ethics approval was obtained from the University of
Manitoba’s Health Research Ethics Board (H2009-351) as
well as the Kenyatta National Hospital/University of
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Nairobi - Ethics & Research Committee (P273/09/2009).
Women provided signed informed consent to participate
in the study.
Results
Data was available for 503 women (325 from PMH and
178 from BDHC), ranging in age from 18 to 49. Table 1
includes a description of the sample characteristics broken
down by site. The average age was 29.4 and the majority
of women were married (78.5%). There were significant
differences between the groups recruited from the differ-
ent facilities: women accessing services at BDHC were
younger, (74.1% were under 30 years of age, as opposed to
43.1% at PMH), predominantly Luo (70.8%), and of lower
socioeconomic status. They were also more likely to have
moved to the area within the past two years.
HIV and treatment history
More than half the women reported contracting HIV more
than a year before the pregnancy and 62.6% were receiving
ART, with the majority of infected women reportedly initi-
ating therapy within the previous year (Table 2). The most
common reason given for initiating therapy was low immu-
nity. There were significant differences between women
recruited from different sites in terms of HIV status and
access to ART as women accessing services at PMH
Table 1 Socio-demographic characteristics of sample (N;%)
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reported being HIV-positive for longer than women at
BDHC and were more likely to be receiving ART, possibly
due to the older average age (Table 2).
Antenatal care
The majority of women presented for their first ANC
visit between 21 and 28 weeks gestation (table 3) with
only 15.3% of women attending their first ANC visit at
20 weeks gestation or less. The vast majority of women
attended less than four ANC visits (88.8%).
There were significant differences in gestational age at
first visit between groups at the two health facilities, as the
majority of women at BDHC attended before 28 weeks
(58.4% presented between 21 and 28 weeks) while 40.6%
of women accessing care at PMH only presented after 28
weeks. Only 4% of women accessing services at BDHC
attended four or more ANC visits, compared to 15.3% at
PMH.
Counselling and testing
The majority of women participating in our study
reported receiving PMTCT counselling during their first
ANC visit (86%, table 3) -with no difference across sites-
while 19.8% received sdNVP during this visit. Less than a
third of women (31.34%) had been counselled on contra-
ception during ANC visits for this pregnancy, and only
half reported the pregnancy as a planned pregnancy.
Disclosure rates were relatively high among the
women in our sample, with almost three quarters
responding that they had disclosed to their partners and
60.8% reportedly doing so immediately following diag-
nosis (Table 3). The main reasons provided for disclo-
sure were to protect the health of their partners (53.4%)
and themselves (17.7%). However, almost 40% of women
did not know their partner’s HIV status; women from
BDHC were less likely to know their partner’s status.
TB testing was rare in with only 10% of women being
tested during this pregnancy or a previous pregnancy
(Table 3): 10.4% were tested during this pregnancy,
10.9% during a previous pregnancy, with no difference
between sites. Testing was discussed with 16.7% of the
women, with slightly more women participating in dis-
cussions at BDHC than PMH (15.4% and 19.1%,
respectively).
Discussion
There is evidence that Kenya has made progress in
PMTCT as HIV incidence among children between six
weeks and one year is estimated to have declined from
27% to 10-15% within five years [3]. Our results show
that, in our study population, there is high coverage for
some recommendations, such as PMTCT counselling
(86%) or provision of nevirapine to newborns: prelimin-
ary analysis of follow up data in our study (not pre-
sented here) suggests that 91.9% of newborns received
sdNVP after birth, compared to 71% of mothers. How-
ever, implementation of other recommendations still
faces challenges, especially in the context of the 2012
PMTCT guidelines and there focus on earlier treatment
with Option B.
Table 2 HIV and treatment history (N;%)
Variables Pumwani (N=325) Baba Dogo (N=178) Total (N=503) p
Length had HIV <1 Year
1 - <2 Years
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PMH is a major maternity hospitals in Nairobi and con-
sidered a “model institution for the PMTCT programme
in Kenya”, one of the first institutions to offer PMTCT
services based on national guidelines [4]. As such, PMH
receives many referrals from surrounding health centres
which could account for the greater client diversity and
the higher number of women attending four or more
ANC visits - as these may be higher risk pregnancies. It is
also plausible that women may want to deliver at this facil-
ity but receive their antenatal care elsewhere. This could
contribute to the higher number of women whose first
ANC visit at PMH was at a later gestational age, as they
register only in time for delivery. This trend is also evident
in the higher number of women presenting at PMH that
could not be enrolled in the study as they were past the
cut off (36 weeks). At BDHC, a community health centre,
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only five women were excluded for this reason, as opposed
to 62 at PMH. The persistence of implementation chal-
lenges across our study sites, despite the significant differ-
ences in type of facility and clients served, suggest that the
challenges identified are not facility-specific but are indica-
tive of broader, systemic issues. Although we cannot gen-
eralize from our sample, we could speculate that these
systemic issues could also pose barriers to the effective
implementation of PMTCT guidelines elsewhere and
could potentially be exacerbated by Kenya’s recent move
to free maternal health care, which could increase patient
load [5].
None of the women in our sample presented for ANC
prior to 20 weeks gestation. Although presenting to an
ANC clinic at 20 weeks gestation fits with previous
PMTCT guidelines, it poses a challenge to the earlier
initiation of ART at 14 weeks proposed in the 2012
guidelines. Earlier initiation will only be feasible if
women and health care providers are made aware of the
importance of earlier ANC visits and women have
access to antenatal care before 20 weeks gestation. The
high percentage of women in our sample who attended
four or less ANC visits also suggests that monitoring
women once they are initiated on treatment may be
complicated, more so since Efavirenz is indicated as part
of the first line ARV regimen for women with no expo-
sure to nevirapine, or where the exposure occurred
more than 12 months prior. Though the guidelines
allows for the substitution of nevirapine for Efavirenz
during the first trimester, Palombi and colleagues (2011)
have criticized the inclusion of Efavirenz in contexts
that may provide limited monitoring due to the lack of
knowledge of its effects on later stages of pregnancy, the
potential for lifelong Efavirenz use, and the risk of hepa-
tic toxicity, amongst others [6]. Hepatic toxicity is also a
concern with nevirapine and would still require follow
up. Providing adequate monitoring of treatment will be
complicated if women attend less than four ANC visits
or if women access care at multiple facilities and there
is no continuity of care – preliminary analysis of follow
up data from our study (not presented here) suggest
that many women access ANC at multiple sites. The
PMTCT guidelines state that women should be given
sdNVP (for themselves and their infants) during “first
contact” [3]. This is especially important in Kenya where
a high percentage of women deliver outside of health-
care facilities. Yet, less than 20% of women in our sam-
ple, regardless of site, reported receiving the nevirapine;
this is lower than what has been previously reported in
Kenyan context [7]. Although Nairobi province has the
lowest prevalence of home deliveries in Kenya, with an
estimated 9.9% of deliveries taking place at home, it is
possible the rates may differ among groups in the city
since increased number of home deliveries tend to be
associated with lower education and fewer ANC visits [9].
Therefore, the potential for transmission remains, espe-
cially considering that not all women may take sdNVP,
even if they have it in their possession [2]. It is also possi-
ble that the nevirapine was given at later ANC visits, as
has been reported elsewhere in Kenya [2] – this seems to
be supported by preliminary analysis of our follow up data
(not presented here) that suggest that 91.9% of newborns
received sdNVP following birth and 71% of mothers
received sdNVP at the onset of labour. While the high
coverage at labour is encouraging, this still deviates from
the guidelines that clearly state that sdNVP should be
given to women at first contact.
According to the Essential Package of Integrated
Antenatal Care Services outlined in Kenya’s PMTCT
guidelines, women should receive counselling in accor-
dance with positive prevention principles and be tested for
opportunistic infections such as TB during ANC. Contra-
ception information and encouragement to disclose are
two elements of positive prevention included in counsel-
ling. Very few women in our study had discussed contra-
ception with a health care provider, although this may be
due to the fact that the data used for this analysis was col-
lected during enrolment, at which time women may only
have attended their first ANC visit. It is highly likely that
family planning and contraception would only be dis-
cussed at later visits, or post-partum [9], and we will
explore this in analysis of our follow up data. However,
the high percentage of women who reported their current
pregnancies as unplanned seem to support the idea that
access to contraception is still limited for HIV-positive
women in Kenya, and the lack of discussion of family
planning during ANC visits presents a missed opportunity.
It also contradicts the importance accorded to reducing
unplanned pregnancies among HIV positive women in the
guidelines – the second prong of the adopted four-prong
approach to PMTCT. Barriers to accessing contraception
including non-disclosure, lack of staff with adequate train-
ing in family planning counselling or lack of time, ideol-
ogy, and gender inequity will need to be addressed for the
guidelines to effectively reduce PMTCT [1,10].
Although more than two thirds of the women in our
sample had disclosed their status to their partners, this
data was collected in the context of a study that sent
text messages about PMTCT to participants and where
disclosure had initially been an inclusion criteria. Given
that the majority of women in our study used phones
that belonged to either their partners or family mem-
bers, it is plausible that many women who had not dis-
closed may have declined participation for fear of
involuntary disclosure. Women’s lack of knowledge
about their partner’s status further indicates that discus-
sions about HIV status and disclosure is still a challenge.
This lack of discussion decreases the potential for men
du Plessis et al. BMC Health Services Research 2014, 14(Suppl 1):S10
http://www.biomedcentral.com/bmchealthservres/content/14/S1/S10
Page 7 of 9
to be involved in PMTCT, increasing challenges to
many aspects of the PMTCT guidelines, including the
use of condoms [1].
The guidelines state that all pregnant women who are
HIV positive should be screened for TB. However, our
data suggests that TB testing is rare, both at PMH and
BDHC, suggesting that this is also a systemic issue that
may need to be addressed at a higher level. Given the
high rates of co-infection in Africa, guidelines have also
suggested that TB and HIV services be integrated, but
studies from Cameroon and South Africa have discussed
the barriers to this posed by local infrastructure and
human resource availability [11]. Similar barriers may
need to be addressed in the context of PMTCT, specifi-
cally in the context of free maternal health and the
resultant increase in patient load.
Limitations
The data presented here was collected in the context of a
RCT examining the role of mHealth in PMTCT. The
focus on pregnant women accessing PMTCT services lim-
ited our sample to women who are HIV positive and we
cannot compare access to ANC with that of HIV negative
pregnant women. Given that the data was collected in the
context of a RCT, the sample was not randomly selected
so our findings are only applicable to the population stu-
died and cannot be generalized to the population of HIV-
positive women attending ANC in Kenya. The generaliz-
ability of our findings may also be affected by the study
setting: the study was conducted at only two facilities in
urban areas and PMH is a major health centre. It is more
plausible that these centres would have the infrastructure
needed to adhere to the guidelines than those in rural
areas. Caution is warranted in extrapolating results to
HIV-positive women in Kenya generally.
The primary purpose of our study was to examine the
role of mHealth in PMTCT and not to examine the fide-
lity of guideline implementation. As a result, some indi-
cators of guideline implementation, such as HIV testing
or the obstetric management and care received during
delivery, included in other studies may have been
excluded (see for instance Musalia et al., 2010 [4]). Simi-
larly, drawing blood samples for CD4 counts was part of
our study protocol and could not be assessed as an ele-
ment of the guidelines. Another limitation is our reliance
on preliminary analysis of the data collected at enrolment
and excluding data from follow-up questionnaires (not
yet completed) which limited the scope of the data we
could present to illustrate challenges to implementation.
Conclusions
The WHO’s 2010 revised PMTCT guidelines moved
towards reducing the gaps between standard of care for
PMTCT in high and low resource settings. This has led
to renewed optimism for elimination of mother-to-child
transmission and meeting the targets set out by the
Joint United Nations Programme on HIV/AIDS. How-
ever, guideline implementation continues to face chal-
lenges such as late presentation for care after 20 weeks
gestation, less than four ANC visits, poor screening for
opportunistic infections such as TB, poor contraception
coverage, and low disclosure rates. Effective scale up
and implementation of PMTCT services requires that
such ongoing program challenges be identified and
appropriately addressed, with consideration of the local
context. The greatest ongoing challenge to PMTCT is
not knowing what needs to be done, but ensuring that
what needs to be done is implemented.
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